The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes

Background & aimsThe effect of change in non-alcoholic fatty liver disease (NAFLD) status on incident diabetes has not been well studied. We aimed to investigate the association of NAFLD development and remission with the risk of incident diabetes during a median of 3.5-year follow-up.Method...

Full description

Bibliographic Details
Main Authors:	Congling Chen, Yuecheng Zhang, Yujuan Fan, Zhen Ying, Qing Su, Xiaoying Li, Li Qin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Endocrinology
Subjects:	non-alcoholic fatty liver disease incident diabetes obesity type2 diabetes mellitus (T2DM) prevention
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1108442/full

Similar Items

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
by: Daniel J. Cuthbertson, et al.
Published: (2021-01-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: A. E. Bagriy, et al.
Published: (2021-06-01)

Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies
by: Dandan Song, et al.
Published: (2021-08-01)

Quantification of liver fat deposition in obese and diabetic patients: A pilot study on the correlation with myocardium and periapical fat content
by: Xi Chen, et al.
Published: (2022-06-01)

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
by: Mikhaïl A. Van Herck, et al.
Published: (2019-02-01)

Resistin as a Marker of Liver Function Disorder in Combined Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: L.V. Zhuravliova, et al.
Published: (2015-09-01)

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease
by: Georgios Kranidiotis, et al.
Published: (2013-05-01)

The level of plasma homocysteine in patients with non-alcoholic fatty liver disease in combination with type 2 diabetes
by: V. F. Orlovskiy, et al.
Published: (2015-06-01)

The Association between Non-Alcoholic Fatty Liver Disease and Dynapenia in Men Diagnosed with Type 2 Diabetes Mellitus
by: Atilla Bulur, et al.
Published: (2023-01-01)

Association of the Non‐Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross‐sectional study in China
by: Nengguang Fan, et al.
Published: (2021-06-01)

Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
by: Hydar El Jamaly, et al.
Published: (2022-01-01)

Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus
by: Hui-Ju Tsai, et al.
Published: (2023-03-01)

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the problem of conjunction and phasing
by: E. V. Kiseleva, et al.
Published: (2021-10-01)

Association between hemoglobin glycation index and non‐alcoholic fatty liver disease in the patients with type 2 diabetes mellitus
by: Meng Wang, et al.
Published: (2023-11-01)

Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study
by: Niloofar Deravi, et al.
Published: (2023-06-01)

Osteoporosis risk prediction in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
by: Yu. A. Titova, et al.
Published: (2020-10-01)

Implications of comorbidities in nonalcoholic fatty liver disease
by: Sherlot Juan Song, et al.
Published: (2023-04-01)

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease
by: Andrea R. López-Pastor, et al.
Published: (2020-09-01)

Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
by: Miyake Teruki, et al.
Published: (2018-09-01)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
by: Fuxi Li, et al.
Published: (2021-05-01)

Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study
by: Zahra Heidari, et al.
Published: (2022-03-01)

Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease
by: Hui Zhang, et al.
Published: (2023-11-01)

METABOLIC TANDEM TARGETS: NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS
by: L. A. Zvenigorodskaya, et al.
Published: (2018-01-01)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
by: Ludovico Abenavoli, et al.
Published: (2023-03-01)

Relationship between sarcopenia and fatty liver in middle-aged and elderly patients with type 2 diabetes mellitus
by: Li Quan, et al.
Published: (2024-04-01)

The Correlation Between Leg Muscle Mass Index and Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
by: Liu M, et al.
Published: (2023-12-01)

Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement
by: Zengzhe Zhu, et al.
Published: (2022-09-01)

MALAT1 and MEG3 genes expression in non-alcoholic fatty liver disease in type 2 diabetes mellitus patients: a case-control study
by: Eman Yousef Moursi, et al.
Published: (2023-12-01)

Risk factors in nonalcoholic fatty liver disease
by: Eunji Ko, et al.
Published: (2023-02-01)

The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study
by: Xing Y, et al.
Published: (2022-02-01)

Non-invasive fibrosis markers and elastography in diagnosis of fibrosis severity in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
by: O. V. Zemlianitsyna, et al.
Published: (2020-02-01)

Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry
by: Ivan Ivanovich Dedov, et al.
Published: (2017-05-01)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
by: Byung-Wan Lee, et al.
Published: (2020-06-01)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
by: Kyung-Soo Kim, et al.
Published: (2019-04-01)

A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China
by: Xue M, et al.
Published: (2021-02-01)

Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease
by: Dug-Hyun Choi, et al.
Published: (2018-09-01)

INSULIN-LIKE GROWTH FACTOR-1, CYTOLYSIS AND CHOLESTASIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS
by: L. V. Zhuravlyova, et al.
Published: (2014-07-01)

INSULIN-LIKE GROWTH FACTOR-1, CYTOLYSIS AND CHOLESTASIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS
by: L. V. Zhuravlyova, et al.
Published: (2014-07-01)

Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease
by: Hidetaka Hamasaki
Published: (2019-08-01)

The Frequency of Non-Alcoholic Fatty Liver Disease in Adults with Diabetes Mellitus
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01)